2019 Innovation To Commercialization (I2C) award recipients

The Innovation to Commercialization (I2C) Program is designed to help researchers advance discoveries or inventions towards commercialization by supporting commercialization activities that strengthen the value of their intellectual property, facilitate collaboration and attract future investment.

In its third year, we were pleased to announce nine successful award recipients for the 2019 competition. These researchers are advancing health innovations that range from new nanomedicines for type 2 diabetes; developing a safe and effective analgesic for chronic pain relief; and creating a smart, multifunctional wound dressing for continuous monitoring and treatment of chronic injuries.

Host institution

University of British Columbia

Project title

A GlycoCaged drug delivery system to improve the treatment of inflammatory bowel disease

Read more

Host institution

University of British Columbia

Project title

Novel bioengineered probiotics increase colonization and persistence in the gut enhancing bioavailability and their therapeutic potential for inflammatory bowel disease

Read more

Host institution

University of British Columbia

Project title

Improving cancer immunotherapy using G-CSF-blocking antibodies to overcome myeloid cell-mediated immunosuppression

Read more

Host institution

University of British Columbia

Project title

Developing a safe and effective analgesic for chronic pain relief

Read more

Host institution

University of British Columbia

Project title

Novel nanomedicines for resolving inflammation as a treatment for type 2 diabetes

Read more

Host institution

University of Victoria

Project title

A smart multifunctional wound dressing for continuous monitoring and treatment of chronic injuries

Read more

Team members

Host institution

University of British Columbia

Project title

Technology for image-based screening to enhance protein production

Read more

Host institution

University of British Columbia

Project title

Biomarker tests to diagnose and prognose acute exacerbations of chronic obstructive pulmonary disease

Read more

Team members

Host institution

University of Victoria

Partner(s) 

Pacific Parkinson's Research Institute 

Project title

3D bioprinting personalized neural tissues for drug screening

Read more